InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Browse the detailed record of transactions filed by Dolsten Mikael, Director. Officer active across 3 companies, notably Agilent Technologies, INC.. In total, 13 disclosures have been recorded. Total volume traded: €9k. The latest transaction was filed on 11 May 2022 — Cession. Regulator: SEC (Form 4). All data is free.
Declarations13 total
14,312 shares
Common Stock
SEC:0001193125-26-224624:0·
14,312 shares
Common Stock
SEC:0001193125-26-224624·
€9,391200 shares@ €46.95370.0000% mcap0.1% of flow
Common Stock
SEC:0001225208-22-006909:0·
€221,5791,785 shares@ €124.13410.0007% mcap57.0% of flow
Common Stock
SEC:0001127602-22-010048:0·
€2m62,022 shares@ €24.60330.0011% mcap14.1% of flow
Common Stock
SEC:0001225208-22-004229:0·
€1m29,744 shares@ €42.64260.0009% mcap11.7% of flow
Common Stock
SEC:0001225208-22-003662:0·
€1m29,767 shares@ €41.37120.0009% mcap11.3% of flow
Common Stock
SEC:0001225208-22-003473:0·
€2m71,187 shares@ €26.61870.0013% mcap55.5% of flow
Common Stock
SEC:0001225208-21-015184·
€2m71,187 shares@ €26.61870.0013% mcap17.4% of flow
Common Stock
SEC:0001225208-21-015184:0·
€2m76,135 shares@ €19.92870.0011% mcap44.5% of flow
Common Stock
SEC:0001225208-21-013883·
€2m76,135 shares@ €19.92870.0011% mcap14.0% of flow
Common Stock
SEC:0001225208-21-013883:0·
€83,655567 shares@ €147.53970.0003% mcap100.0% of flow
Common Stock
SEC:0001127602-21-025723·
€83,655567 shares@ €147.53970.0003% mcap21.5% of flow
Common Stock
SEC:0001127602-21-025723:0·
13 of 13 declarations
About Dolsten Mikael
Mikael Dolsten is a Director and President of R&D at Agilent Technologies, Inc., Pfizer Inc, and Apellis Pharmaceuticals, Inc. He plays a key role on the boards, bringing his expertise in research and development. His experience allows him to contribute to innovation and strategy for these companies.
